PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
01-Sep-2020 Humoral immune response to SARS-CoV2 in Iceland deCODE genetics
01-Sep-2020 Sanofi to commence tender offer for acquisition of Principia Biopharma Inc. Sanofi
01-Sep-2020 Hard-to-treat pancreatic cancer hijacks immune system and could be targeted with immunotherapies The Institute of Cancer Research
01-Sep-2020 Empagliflozin (Jardiance®) meets primary endpoint in Phase III heart failure trial with and without diabetes Boehringer Ingelheim and Eli Lilly and Company (Lilly)
01-Sep-2020 SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics SOTIO
01-Sep-2020 Biocartis Expands Collaboration with LifeArc Biocartis Group NV
01-Sep-2020 Oxurion NV Reports First Patient Dosed in Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME) Oxurion NV
01-Sep-2020 Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S. Sanofi
01-Sep-2020 Induction subsidiary Horizon achieves earn-out target ahead of schedule Induction Healthcare Group PLC
01-Sep-2020 Emergex Vaccines forms US subsidiary (Emergex USA) by acquisition of laboratories, technology and assets of US-based T cell specialist biotech ImmProNano Emergex Vaccines Holding Limited
01-Sep-2020 BioVersys Announces CHF 19 Million Financing to Advance Novel AMR Candidates into Clinical Development BioVersys
01-Sep-2020 Chromologics Announces Seed Round Led by Novo Holdings and Supported by Vækstfonden and Nordic FoodTech VC Chromologics
01-Sep-2020 Oxurion NV Reports First Patient Dosed in Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME) Oxurion NV
01-Sep-2020 4D pharma hosts R&D webinar providing an overview of world leading Live Biotherapeutic discovery platform, MicroRx(R) 4D pharma plc
01-Sep-2020 New 12-month analysis data from ETNA-AF non-interventional study show low bleeding and ICH rates in frail and ageing AF patients on LIXIANA®▼ (edoxaban) during routine clinical care Daiichi Sankyo Europe
01-Sep-2020 CluePoints Joins Forces with Global Growth Investor Summit Partners to Expand Market Leadership Position in Risk-Based Quality Management CluePoints S.A.
01-Sep-2020 NILEMDO®▼(bempedoic acid) delivers cholesterol lowering in addition to statin therapy which is maintained during 2.5 years of treatment Daiichi Sankyo Europe GmbH
01-Sep-2020 Imfinzi approved in the EU for the treatment of extensive-stage small cell lung cancer AstraZeneca
01-Sep-2020 Novo Holdings bolsters Principal Investments team with key US appointments Novo Holding A/S
01-Sep-2020 Nordic Nanovector to Present at Upcoming Pareto Securities 11th Healthcare Conference Nordic Nanovector ASA